The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)

NCT02393183 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Do not access to the drug

Conditions

Thyroid Eye Disease

Interventions

DRUG: ASTED
DIETARY_SUPPLEMENT: Selenium
OTHER: Placebo

Sponsor

Iran University of Medical Sciences